2Thanvi B, Treadwell S, Robinson T. Early neurological deterioration in acute iscbemic stroke : predictors, mechanisms and management [ J]. Postgrad Med J,2008 ;84:412-7.
3Awadh M, MacDougall N, Santosh C, et al. Early recurrent ischemic stroke complicating intravenous thrombolysis for stroke:incidence and association with atrial fibrillation[ J]. Stroke ,2010 ;41 : 1990-5.
4Ois A, Martinez-Rodringuez JE, Munteis E, et al. Steno-occlusive arterial disease and early neurological deterioration in acute ischemic stroke [ J]. Cerebrovasc Dis, 2008 ; 25 : 151-6.
5Hofmann MA, Papa F, Bocola V, et al. Hyperhomocystein enhances vascular inflammation and accelerates atherosclerosis in a murine model [J]. J Clin Invest,2001 ;107:65.
6Winbeck K, Poppert H, Etgen T, et al. Progonstic relevance of early serial c-reactive protein measurements after first ischemic stroke [ J]. Stroke, 2002 ;33:2459-64.
7Emsley HC, Smith C J, Gavin CM, et al. An early and sustained peripheral inflammatory response in acute ischaemic stroke :relationships with infection and atherosclerosis[J]. J Neuroimmuno1,2003 ; 139 ( 1 ) :93-101.
8Emanueli C, Madeddu P. Angiogenesis therapy with human tissue kallikrein for the treatment of ischemic diseases[ J]. Arch Mal Coeur,2004 ; 97(6) :679-87.
9Campbell DJ. Kallikrein-kinin system in humans [J]. Clin Exp Pharm Physio1,2001 ;28 ( 12 ) : 1060-5.
10Leeb-Lundberg LM,Marceau F, Mailer-Esterl W,et al. Intermational u nion of pharmacology XLV, classification of the kinin receptor family from molecular mechanisms to pathophysiological consequences [J]. Pharmacol Rev ,2005 ;57 ( 1 ) :27-77.
